MS4A1 and head and neck squamous cell carcinoma: In addition to HNSCC, many other cancer types also demonstrated such discrepancies for patient outcome prediction by various TIL-B detection approaches (e.g. a single CD20 marker vs. multigene TIL-B detection)7,12–19.